After bicyclol-treated, the levels of TNF-α and IL-1β were decreased and the pathological and ultrastructural changes of liver tissue are also weakened, it is demonstrated that bicyclol markedly inhibiting the inflammation in T2DM–NAFLD rat. This evidence concerns the gene IL1B and type 2 diabetes mellitus.